Related Experiment Video
Updated: Apr 13, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Managing residual risk after myocardial infarction among individuals with low cholesterol levels
Lisandro D Colantonio1, Vera Bittner2
1Department of Epidemiology, University of Alabama at Birmingham, 1530 3rd Avenue South, RPHB 217C, Birmingham, AL 35294, USA.
Insights
Many acute myocardial infarction patients have low LDL cholesterol but still face recurrent event risk. This review covers management strategies for this high-risk group, addressing atherosclerosis, dyslipidemia, and therapy adherence.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- A significant proportion of acute myocardial infarction (AMI) patients present with low-density lipoprotein cholesterol (LDL-C) levels below 100 mg/dL.
- Despite achieving target LDL-C, these individuals remain at substantial risk for recurrent cardiovascular events.
Purpose of the Study:
- To review and outline management strategies for high-risk AMI patients with residual cardiovascular risk.
- To address the multifaceted nature of residual risk in AMI survivors.
Main Methods:
- Review of current literature on residual risk factors and management in acute myocardial infarction.
- Synthesis of evidence regarding atherosclerosis burden, dyslipidemia, nonlipid risk factors, and therapeutic adherence.
Main Results:
- Residual risk in AMI is multifactorial, influenced by factors beyond LDL-C levels.
- Key contributors include the extent of atherosclerosis, persistent dyslipidemia, nonlipid risk factors, and suboptimal therapy implementation.
Conclusions:
- Effective management requires a comprehensive approach addressing all identified risk factors.
- Optimizing lifestyle and pharmacologic therapies is crucial for mitigating recurrent event risk in this population.
Abstract:
About one-half of individuals with an acute myocardial infarction have a low-density lipoprotein cholesterol level of less than 100 mg/dL at the time of occurrence, but remain at risk for recurrent events. This residual risk is likely mediated by multiple factors, including burden of atherosclerosis, residual dyslipidemia, nonlipid risk factors, and suboptimal implementation of lifestyle therapy and evidence-based pharmacologic therapy. This article reviews management options for this high-risk population.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Cholesterol: Significance and Regulation
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis III: Management
Lipids: Dietary Sources and Requirements
Lipid-Lowering Drugs: Statins and Miscellaneous Agents

